Compare PSEC & ACHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PSEC | ACHC |
|---|---|---|
| Founded | 2004 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 2004 | N/A |
| Metric | PSEC | ACHC |
|---|---|---|
| Price | $2.56 | $14.47 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 1 | 13 |
| Target Price | $2.50 | ★ $24.00 |
| AVG Volume (30 Days) | ★ 4.2M | 3.4M |
| Earning Date | 02-09-2026 | 11-05-2025 |
| Dividend Yield | ★ 21.18% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.18 |
| Revenue | $680,752,000.00 | ★ $3,265,548,000.00 |
| Revenue This Year | N/A | $6.50 |
| Revenue Next Year | N/A | $4.38 |
| P/E Ratio | ★ N/A | $12.39 |
| Revenue Growth | N/A | ★ 4.58 |
| 52 Week Low | $2.45 | $12.63 |
| 52 Week High | $4.47 | $47.08 |
| Indicator | PSEC | ACHC |
|---|---|---|
| Relative Strength Index (RSI) | 47.59 | 40.01 |
| Support Level | $2.45 | $14.05 |
| Resistance Level | $2.53 | $14.74 |
| Average True Range (ATR) | 0.07 | 0.50 |
| MACD | 0.00 | 0.23 |
| Stochastic Oscillator | 45.83 | 60.11 |
Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests mainly in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.